Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
MultiCare Health System Research Institute
Mayo Clinic
Beth Israel Deaconess Medical Center
Sellas Life Sciences Group
Tempus AI